dehydroepiandrosterone has been researched along with monocrotaline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fagan, KA; Homma, N; Imamura, M; Karoor, V; McMurtry, IF; Nagaoka, T; Oka, M; Taraseviciene-Stewart, L; Walker, LA | 1 |
| Bisserier, M; Bonnet, S; Courboulin, A; Jacob, MH; Meloche, J; Paulin, R | 1 |
2 other study(ies) available for dehydroepiandrosterone and monocrotaline
| Article | Year |
|---|---|
Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone.
Topics: Adjuvants, Immunologic; Animals; Blood Pressure; Dehydroepiandrosterone; Enzyme Activation; Gene Expression Regulation, Enzymologic; Hypertension, Pulmonary; Monocrotaline; Pneumonectomy; Pulmonary Artery; Rats; rho-Associated Kinases; rhoA GTP-Binding Protein; Time Factors | 2008 |
Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
Topics: Adult; Animals; Antihypertensive Agents; Apoptosis; Blotting, Western; Bone Morphogenetic Protein Receptors, Type II; Calcium; Cell Proliferation; Cells, Cultured; Dehydroepiandrosterone; Disease Models, Animal; Enzyme Activation; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; In Situ Nick-End Labeling; Inhibitor of Apoptosis Proteins; Male; Membrane Potential, Mitochondrial; MicroRNAs; Microtubule-Associated Proteins; Middle Aged; Monocrotaline; Muscle, Smooth; Myocytes, Smooth Muscle; NFATC Transcription Factors; Proto-Oncogene Proteins c-pim-1; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor; Survivin; Vasodilator Agents | 2011 |